Roviaro15 2004 |
259 (344) |
No spreading |
5y 68.9 |
5 |
78 (23%) conversions, 2 deaths |
Iwasaki16 2004 |
140 |
No spreading |
5y 77.3%
I 80.9%
II 70.3%
|
NR |
100 lobes, 40 segments |
Ohtsuka17 2004 |
95 (106) |
Spreading |
3y 93% |
7.6 |
Survival in only 82 patients, 1 death, 10% conversion |
Walker18 2003 |
158 (178) |
No spreading |
|
6 |
1.8% 30d mortality, 11% conversion |
Gharagozloo23 2003 |
179 |
Simultaneous stapling, no spreading |
5y 83% |
4.1 |
1 death |
Solaini19 2001 |
112 (125) |
No spreading |
|
6.2 |
Survival in 86 patients with NSCLC, 10% conversion |
Lewis22 1999 |
250 |
Simultaneous stapling, no spreading |
3y 83% |
2.8 |
About half of patients were stage II |
Yim20 1998 |
214 (266) |
Spreading |
2y 93% |
NR |
1.8% 30d mortality, 19% conversion |
McKenna21 2006 |
1100 |
No spreading |
|
3 med 4.78 mean |
0.8% mortality, 2.5% conversion, port site recurrence-0.6% |
Onaitis24
|
500 |
No spreading |
2y 80% |
3 |
1% mortality, 1.6% conversion |